Tricida is a California-based pharmaceutical company that develops and commercializes investigational drugs for the treatment of chronic kidney disease.
Business Model:
Revenue: $0
Employees: 51-200
Address: 7000 Shoreline Court
City: South San Francisco
State: CA
Zip: 94080
Country: US
Tricida is a California-based pharmaceutical company that develops and commercializes investigational drugs for the treatment of chronic kidney disease.
Contact Phone:
+14154297800
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/27/2018
IPO Valuation:
$763M
Ticker Symbol:
TCDA
IPO Price:
$19/share
Amount Raised:
$222M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|